Trials / Sponsors / AvenCell Europe GmbH
AvenCell Europe GmbH
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory | Phase 1 | 2024-01-03 |
| Terminated | Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Dise Prostate Cancer | Phase 1 | 2020-11-23 |
| Terminated | Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies Acute Myeloid Leukemia (AML) | Phase 1 | 2020-01-28 |
| Terminated | Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PS Non-small Cell Lung Cancer, Prostate Cancer, Renal Cancer | Phase 1 | 2019-04-15 |
| Terminated | Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia, Relapsed AML, Refractory AML | Phase 1 | 2018-04-11 |